compound 16a Search Results


x-ray diffraction data for single crystal of compounds 4a, 16a, 8a, 12a  (Rigaku Corporation)
90
Rigaku Corporation x-ray diffraction data for single crystal of compounds 4a, 16a, 8a, 12a
X Ray Diffraction Data For Single Crystal Of Compounds 4a, 16a, 8a, 12a, supplied by Rigaku Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/pmc10509164__41467_2023_41253_MOESM1_ESM-407-14-18?v=Rigaku+Corporation
Average 90 stars, based on 1 article reviews
x-ray diffraction data for single crystal of compounds 4a, 16a, 8a, 12a - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
pam_16a  (Autifony Therapeutics)
90
Autifony Therapeutics pam_16a
Pam 16a, supplied by Autifony Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/pm39829151-67-0-8?v=Autifony+Therapeutics
Average 90 stars, based on 1 article reviews
pam_16a - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
reference compound 16a  (King Pharmaceuticals)
90
King Pharmaceuticals reference compound 16a
Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.
Reference Compound 16a, supplied by King Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/pmc03349997-273-9-23?v=King+Pharmaceuticals
Average 90 stars, based on 1 article reviews
reference compound 16a - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
compound 16a, a brs-3 agonist  (Bachem)
90
Bachem compound 16a, a brs-3 agonist
Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.
Compound 16a, A Brs 3 Agonist, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/pmc05956246-62-3-20?v=Bachem
Average 90 stars, based on 1 article reviews
compound 16a, a brs-3 agonist - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
compound 16a  (ReAgent Chemical)
90
ReAgent Chemical compound 16a
Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.
Compound 16a, supplied by ReAgent Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/us09751854-952-28-31?v=ReAgent+Chemical
Average 90 stars, based on 1 article reviews
compound 16a - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
compounds 15a–e and 16a–c  (CEM Corporation)
90
CEM Corporation compounds 15a–e and 16a–c
Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.
Compounds 15a–E And 16a–C, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/pm25798893-116-3-13?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
compounds 15a–e and 16a–c - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
16a chemical compound  (CH Instruments)
90
CH Instruments 16a chemical compound
Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.
16a Chemical Compound, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/10__1002_slash_cber__19861191223-196-1-28?v=CH+Instruments
Average 90 stars, based on 1 article reviews
16a chemical compound - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
compound 16a (x=cl)  (Verlag GmbH)
90
Verlag GmbH compound 16a (x=cl)
Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.
Compound 16a (X=Cl), supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+16a/pm15674982-277-13-8?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
compound 16a (x=cl) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.

Journal: Journal of Medicinal Chemistry

Article Title: Allosteric Modulation of 7 Transmembrane Spanning Receptors: Theory, Practice and Opportunities for CNS Drug Discovery 1

doi: 10.1021/jm201139r

Figure Lengend Snippet: Allosteric Operational Model Parameters Describing the Functional Effect of Various 2-Amino-3-Benzoylthiophenes on ERK1/2 Phosphorylation mediated by the Orthosteric Agonist, R -PIA, at Adenosine A 1 Receptors.

Article Snippet: It should also be noted that the reference compound, 16a , progressed into Phase IIB clinical trials for the treatment of neuropathic pain (King Pharmaceuticals) prior to failing due to lack of efficacy; it is possible that this failure may be attributed to the rather low degree of positive cooperativity, as revealed by the application of the operational model to the in vitro data.

Techniques: Functional Assay, Phospho-proteomics